Published January 1984 | Version v1
Journal article

Modified human fibrinogen labeled with 111In

  • 1. Israel Atomic Energy Commission, Yavne. Soreq Nuclear Research Center

Description

A method for the labeling of human fibrinogen with 111In is reported. The cyclic anhydride of DTPA, either dissolved in dimethyl sulfoxide or as the solid, is first covalently attached to the protein. The modified fibrinogen is then labeled with [111In]acetate, with an average yield of 90 +- 3%. The product obtained is highly clottable and stable in vitro and has potential applications in imaging studies. (author)

Additional details

Publishing Information

Journal Title
Int. J. Appl. Radiat. Isot.
Journal Volume
35
Journal Issue
1
Series
Int. J. Appl. Radiat. Isot.
Journal Page Range
69-70
ISSN
0020-708X